For Patient Advocacy Groups, a Broader Role in Drug Discovery

BOSTON – In the mid-20th century, a cancer patient could die without ever hearing his or her diagnosis. Many doctors, in fact, considered that the ethical thing to do. Since patients had no voice in their treatments, why saddle them with the knowledge of their diseases – which, at the time, could carry considerable social stigma?